The most relevant data showed that, after traumatic brain injury, GPR17 is expressed by OPCs with a decreasing gradient starting from the center of lesion [17], whereas in MS an increased level of GPR17 transcript has been detected in active lesions compared to normal appearing white matter (NAWM) [8]. This evidence concerns the gene GPR17 and myeloid sarcoma.